Levey AS, Stevens LA, Schmid CH, et al.. A new equation to estimate glomerular filtration rate. Ann Intern Med 2009; 150:604–612.
Levey AS, et al.. A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group. Ann Intern Med 1999; 130:461–470.
Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease. Kidney Int Suppl 2013; 3:1–150.
Levey AS, Becker C, Inker LA. Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review. JAMA 2015; 313:837–846.
Inker LA, et al.. KDOQI US commentary on the 2012 KDIGO clinical practice guideline for the evaluation and management of CKD. Am J Kidney Dis 2014; 63:713–735.
Inker LA, et al.. Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 2012; 367:20–29.
Anderson AH, et al.. Estimating GFR among participants in the Chronic Renal Insufficiency Cohort (CRIC) Study. Am J Kidney Dis 2012; 60:250–261.
Schaeffner ES, et al.. Two novel equations to estimate kidney function in persons aged 70 years or older. Ann Intern Med 2012; 157:471–481.
Fan L, et al.. Comparing GFR estimating equations using cystatin C and creatinine in elderly individuals. J Am Soc Nephrol 2014 [Epub ahead of print].
Kilbride HS, et al.. Accuracy of the MDRD (Modification of Diet in Renal Disease) study and CKD-EPI (CKD Epidemiology Collaboration) equations for estimation of GFR in the elderly. Am J Kidney Dis 2013; 61:57–66.
Matsushita K, et al.. Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate. JAMA 2012; 307:1941–1951.
Shlipak MG, et al.. Cystatin C versus creatinine in determining risk based on kidney function. N Engl J Med 2013; 369:932–943.
Lambers Heerspink HJ, et al.. GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials. Am J Kidney Dis 2014; 64:860–866.
Coresh J, et al.. Decline in estimated glomerular filtration rate and subsequent risk of end-stage renal disease and mortality. JAMA 2014; 311:2518–2531.
Matsushita K, et al.. Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis. Lancet 2010; 375:2073–2081.
Hallan SI, et al.. Age and association of kidney measures with mortality and end-stage renal disease. JAMA 2012; 308:2349–2360.
James MT, et al.. Risk of bloodstream infection in patients with chronic kidney disease not treated with dialysis. Arch Intern Med 2008; 168:2333–2339.
Yaffe K, et al.. Higher levels of cystatin C are associated with worse cognitive function in older adults with chronic kidney disease: the chronic renal insufficiency cohort cognitive study. J Am Geriatr Soc 2014; 62:1623–1629.
Kurella M, et al.. Cognitive impairment in chronic kidney disease. J Am Geriatr Soc 2004; 52:1863–1869.
Greco A, et al.. Frailty, disability and physical exercise in the aging process and in chronic kidney disease. Kidney Blood Press Res 2014; 39:164–168.
Kim JC, Kalantar-Zadeh K, Kopple JD. Frailty and protein-energy wasting in elderly patients with end stage kidney disease. J Am Soc Nephrol 2013; 24:337–351.
Anand S, Johansen KL, Kurella Tamura M. Aging and chronic kidney disease: the impact on physical function and cognition. J Gerontol A Biol Sci Med Sci 2014; 69:315–322.
Stevens LA, Levey AS. Use of the MDRD study equation to estimate kidney function for drug dosing. Clin Pharmacol Ther 2009; 86:465–467.
National Kidney Disease Educational Program. CKD and Drug Dosing: Information for Providers. http://nkdep.nih.gov/resources/CKD-drug-dosing.shtml. Accessed May 22, 2015.